Skip to Main Content

Filter:

Early Detection and Screening

1 Results

Invited Speaker Abstract
Open Archive
Clinical relevance of circulating microRNAs as lung cancer biomarkers
Journal of Thoracic Oncology
Vol. 11Issue 2SupplementS2Published in issue: February, 2016
- Mattia Boeri
- Gabriella Sozzi
- Ugo Pastorino
Cited in Scopus: 0
Improvements in clinical management of lung cancer have been modest over the last 20 years and with almost 1.6 million deaths worldwide (19% of the total) it still has the highest mortality rate among cancers. So far no valid biomarker has proven to be useful in lung cancer clinical practice and in reducing mortality. Technical limitations, as well as genetic and biological tumor heterogeneity have likely limited the successful identification of tumor-specific markers. An interesting landmark to identify novel and more reliable biomarkers is searching for candidates by looking not only at the tumor itself but also at the interplay between the tumor and the host with the aim to identify changes related to the biological reactivity of the host to a developing cancer.